Dr David Evans
02 Junio 2006 - 12:11PM
UK Regulatory
RNS Number:0192E
Amphion Innovations PLC
02 June 2006
Amphion Innovations PLC
Dr. David Evans
London, 2 June 2006 - It is with great sadness that Amphion Innovations plc
(AMP.L) announces the sudden and untimely death of Dr. David Evans, the CEO of
our partner company WellGen, Inc. on 1 June 2006.
Dave's passing is a tragic loss for his family, his friends, and his colleagues
at WellGen. It is also a deep personal and professional loss for the staff of
Amphion. Dave will be remembered for his great contributions in the field of
agricultural biotechnology and as a pioneer in establishing and leading the
nascent field of nutrigenomics. More importantly Dave will be remembered for
his great sense of humor and compassion.
Our sympathies are with his wife Kitty and his family.
Enquiries:
Richard Morgan, Chief Executive
1 (212) 210 6223
Richard Mansell-Jones, Chairman
020 734 99138
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSSMFMESMSEIM
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024
Real-Time news about Amphion Innovations Plc (London Stock Exchange): 0 recent articles
Más de Amphion Innovations Artículos de Noticias